Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Poster Presentations

Diabetes

A leu402pro Mutation of the Non-hla Gene il18rap in Aggressive Neonatal Type 1 Diabetes Mellitus
aPediatric Endocrine and Diabetes Unit, Children’s University Hospital, Geneva, Switzerland; bGenetic Medicine and Development, University Medical Center, Geneva, Switzerland
hrp0082p1-d1-58
Evaluation of S-100B, Antioxidant and Oxidative Capacity Before and After the Treatment in Children with Diabetic Ketoacidosis
aDepartment of Pediatric Endocrinology, University of Harran, Sanliurfa, Turkey; bDepartment of Biochemistry, University of Harran, Sanliurfa, Turkey
hrp0082p1-d1-61
Th17 Cells in Children with New Onset Type 1 Diabetes
aDepartment of Pediatric Endocrinology and Diabetology, Medical University of Lublin, Lublin, Poland; bDepartment of Clinical Immunology, Medical University of Lublin, Lublin, Poland
hrp0082p1-d1-63
Biomarkers of Subclinical Inflammation in an Infant-Juvenile Population with Type 1 Diabetes
aMedicine Faculty, National University of Tucuman, Tucuman, Argentina; bBiochemical Faculty, National University of Tucuman, Tucuman, Argentina
hrp0082p1-d1-64
Glycaemic Control and Acute Complications in European Children, Adolescents, and Young Adults With Type 1 Diabetes in the Teens Study
aInstitute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel; bPediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Boston, Massachusetts, USA; cSanofi, Paris, France; dSanofi, Chilly Mazarin, France; eKinder und Jugendkrankenhaus ‘Auf der Bult’, Hannover, Germany; fNutrition Department, Hospital de Pediatría J P Garrahan, Buenos Aires, Argentina; gSection of Psychology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; hNU Hospital Group, Department of Pediatrics, Uddevalla and Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; iHosted by West Midlands Strategic Clinical Network, Birmingham, UK; jJaeb Center for Health Research, Tampa, Florida, USA; kUniversity Hospitals (UZ), Leuven, Belgium
hrp0082p1-d1-65
Metabolic Consequences of Antipsychotic Medication in Youths with Type 1 Diabetes: Analysis from the Prospective Nationwide German and Austrian Diabetes Survey DPV
aCharité - Universitätsmedizin Berlin, Berlin, Germany; bInstitute of Epidemiology and Medical Biometry, University Ulm, Ulm, Germany; cGemeinschaftskrankenhaus Herdecke, Child and
Adolescent Psychiatry, Herdecke, Germany; dFilderklinik,
Filderstadt, Germany; eUniversity Carl Gustav Carus Dresden, University Hospital for Children and Adolescents, Dresden, Germany; fSana Hospital Berlin Lindenhof, Hospital for Children and Adolescents, Berlin, Germany; gMedical University Vienna, University Hospital for Children and Adolescents, Vienna, Austria
hrp0082p1-d1-66
Evaluation of Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes
aDepartment of Pediatrics, Regional Hospital of Bolzano, Bolzano, Italy; bDepartment of Pediatrics, Santa Chiara Hospital of Trento, Trento, Italy
hrp0082p1-d1-68